These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 23820984)

  • 1. Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.
    Daulatzai MA
    Neurotox Res; 2013 Oct; 24(3):407-59. PubMed ID: 23820984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of stress, depression, and aging in cognitive decline and Alzheimer's disease.
    Daulatzai MA
    Curr Top Behav Neurosci; 2014; 18():265-96. PubMed ID: 25167923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.
    Daulatzai MA
    Neurotox Res; 2016 Oct; 30(3):295-337. PubMed ID: 27339162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly.
    Daulatzai MA
    J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential predictors of hippocampal atrophy in Alzheimer's disease.
    Dhikav V; Anand K
    Drugs Aging; 2011 Jan; 28(1):1-11. PubMed ID: 21174483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
    Ponne S; Kumar CR; Boopathy R
    Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.
    Daulatzai MA
    Neurotox Res; 2015 Jul; 28(1):55-93. PubMed ID: 25911292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D
    Yamini P; Ray RS; Chopra K
    Inflammopharmacology; 2018 Feb; 26(1):39-55. PubMed ID: 28702935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats.
    Ashok A; Rai NK; Tripathi S; Bandyopadhyay S
    Toxicol Sci; 2015 Jan; 143(1):64-80. PubMed ID: 25288670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
    Sultana R; Banks WA; Butterfield DA
    J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.
    Scheff SW; Ansari MA; Mufson EJ
    Neurobiol Aging; 2016 Jun; 42():1-12. PubMed ID: 27143416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.
    Baluchnejadmojarad T; Mohamadi-Zarch SM; Roghani M
    Metab Brain Dis; 2019 Dec; 34(6):1747-1759. PubMed ID: 31422512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
    Velazquez R; Shaw DM; Caccamo A; Oddo S
    Mol Neurodegener; 2016 Jul; 11(1):52. PubMed ID: 27412291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.
    Daulatzai MA
    Neurochem Res; 2012 Dec; 37(12):2627-58. PubMed ID: 22886562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.